抗磷脂综合征
医学
分类
同种类的
命名法
重症监护医学
血栓形成
内科学
计算机科学
人工智能
分类学(生物学)
数学
植物
生物
组合数学
作者
Gilberto Pires da Rosa,Paulo Bettencourt,Ignasi Rodríguez‐Pintó,Ricard Cervera,Gerard Espinosa
标识
DOI:10.1016/j.autrev.2020.102689
摘要
The classification criteria for antiphospholipid syndrome (APS) generate discussion, with a growing impression that certain patients not fulfilling these criteria might be inadequately excluded from the classification. Nonetheless, these “non-criteria” patients are heterogeneously defined across different publications. We reviewed the “non-criteria” APS subgroups depicted in the literature and attempted to organize these subsets in a nomenclature proposal that could be used for research purposes. We established four potential patient profiles, grouped under the broad term “non-criteria APS”: (A) “Seronegative APS”: patients fulfilling clinical criteria, plus “non-criteria” manifestations, with persistently negative antiphospholipid antibodies (aPL); (B) “Clinical non-criteria APS”: patients with “non-criteria” manifestations, plus aPL positivity fulfilling the classification criteria; (C) “Incomplete laboratory APS”: patients fulfilling clinical criteria, plus positive aPL, but not fulfilling the classification criteria (low titer aPL); and (D) “Laboratory non-criteria APS”: patients fulfilling clinical criteria, with negative or low titer criteria aPL, plus positive “non-criteria” aPL. This categorization could allow for a more homogeneous research approach to APS, enabling more sustained and universal conclusions.
科研通智能强力驱动
Strongly Powered by AbleSci AI